|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.065 EUR | -1.40% |
|
-0.77% | -15.19% |
| 03-05 | Barclays downgrades TF1 amid a strained advertising market | |
| 03-05 | TF1 Downgraded by Barclays Amid Tight Advertising Market |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 5.85 | 5.49 | 5.16 | 4.76 | 3.82 | |||||
Return on Total Capital | 10.64 | 9.82 | 8.78 | 7.86 | 6.19 | |||||
Return On Equity % | 13.28 | 10.03 | 10.1 | 10.39 | 7.84 | |||||
Return on Common Equity | 13.35 | 9.7 | 10.06 | 10.28 | 7.45 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 39.92 | 43.53 | 42.43 | 49.39 | 47.64 | |||||
SG&A Margin | 19.12 | 21.95 | 21.71 | 17.8 | 18.08 | |||||
EBITDA Margin % | 16.11 | 14.9 | 15.02 | 15.23 | 12.94 | |||||
EBITA Margin % | 15.1 | 13.87 | 13.94 | 12.94 | 11.68 | |||||
EBIT Margin % | 13.65 | 12.89 | 13.12 | 12.18 | 10.16 | |||||
Income From Continuing Operations Margin % | 9.23 | 7.26 | 8.39 | 8.93 | 7.19 | |||||
Net Income Margin % | 9.28 | 7.02 | 8.36 | 8.72 | 6.65 | |||||
Net Avail. For Common Margin % | 9.28 | 7.02 | 8.36 | 8.72 | 6.65 | |||||
Normalized Net Income Margin | 7.61 | 6.26 | 8.17 | 7.63 | 5.7 | |||||
Levered Free Cash Flow Margin | 13.06 | 9.59 | 17.11 | 10.31 | 9.01 | |||||
Unlevered Free Cash Flow Margin | 13.21 | 9.77 | 17.36 | 10.62 | 9.31 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.69 | 0.68 | 0.63 | 0.62 | 0.6 | |||||
Fixed Assets Turnover | 8.3 | 8.62 | 7.64 | 8.2 | 8.69 | |||||
Receivables Turnover (Average Receivables) | 3.12 | 3.02 | 3.03 | 3.36 | 3.38 | |||||
Inventory Turnover (Average Inventory) | 107.62 | 97.66 | 82.38 | 76.19 | 90.76 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.3 | 1.49 | 1.51 | 1.49 | 1.52 | |||||
Quick Ratio | 0.95 | 1.12 | 1.14 | 1.13 | 1.13 | |||||
Operating Cash Flow to Current Liabilities | 0.37 | 0.3 | 0.41 | 0.29 | 0.3 | |||||
Days Sales Outstanding (Average Receivables) | 116.94 | 120.81 | 120.59 | 108.93 | 108.05 | |||||
Days Outstanding Inventory (Average Inventory) | 3.39 | 3.74 | 4.43 | 4.8 | 4.02 | |||||
Average Days Payable Outstanding | 169.35 | 178.36 | 186.76 | 209.76 | 208.13 | |||||
Cash Conversion Cycle (Average Days) | -49.02 | -53.82 | -61.73 | -96.03 | -96.06 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 14.1 | 12.65 | 12.16 | 13.05 | 10.57 | |||||
Total Debt / Total Capital | 12.36 | 11.23 | 10.84 | 11.54 | 9.56 | |||||
LT Debt/Equity | 8.68 | 8.93 | 6.62 | 4.64 | 3.43 | |||||
Long-Term Debt / Total Capital | 7.6 | 7.93 | 5.9 | 4.11 | 3.1 | |||||
Total Liabilities / Total Assets | 52.52 | 48.84 | 46.62 | 45.94 | 43.58 | |||||
EBIT / Interest Expense | 57.14 | 44.9 | 33.12 | 24.53 | 20.83 | |||||
EBITDA / Interest Expense | 70.62 | 54.76 | 40.73 | 31.87 | 27.62 | |||||
(EBITDA - Capex) / Interest Expense | 13.59 | 11.35 | 7.96 | 5.08 | -4.38 | |||||
Total Debt / EBITDA | 0.61 | 0.6 | 0.64 | 0.73 | 0.72 | |||||
Net Debt / EBITDA | -0.33 | -0.64 | -1.17 | -1.17 | -1.49 | |||||
Total Debt / (EBITDA - Capex) | 3.16 | 2.89 | 3.28 | 4.61 | -4.56 | |||||
Net Debt / (EBITDA - Capex) | -1.71 | -3.08 | -5.97 | -7.37 | 9.39 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 16.59 | 3.32 | -8.41 | 2.59 | -2.51 | |||||
Gross Profit, 1 Yr. Growth % | 21.04 | 12.66 | -10.73 | 7.9 | -5.96 | |||||
EBITDA, 1 Yr. Growth % | 23.85 | -4.45 | -3.82 | 9.86 | -12.9 | |||||
EBITA, 1 Yr. Growth % | 23.83 | -5.1 | -1.57 | 0.93 | -14.28 | |||||
EBIT, 1 Yr. Growth % | 71.62 | -2.44 | -2.24 | 1.34 | -13.27 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 315.58 | -18.75 | 5.93 | 9.18 | -21.57 | |||||
Net Income, 1 Yr. Growth % | 307.41 | -21.84 | 8.97 | 7.09 | -25.64 | |||||
Normalized Net Income, 1 Yr. Growth % | 70.36 | -14.97 | 27.09 | 2.51 | -22.34 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 311.54 | -22.43 | 9.64 | 6.59 | -25.77 | |||||
Accounts Receivable, 1 Yr. Growth % | 14.51 | -0.05 | -17.11 | 3.91 | -9.72 | |||||
Inventory, 1 Yr. Growth % | -18.12 | 37.7 | -8.93 | 4.58 | -34.38 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -8.05 | 7.71 | -0.63 | -8.34 | -7.61 | |||||
Total Assets, 1 Yr. Growth % | 10.66 | -2.11 | 0.4 | 6.19 | -3.55 | |||||
Tangible Book Value, 1 Yr. Growth % | 25.61 | 42.03 | 6.69 | -2.23 | 3.77 | |||||
Common Equity, 1 Yr. Growth % | 10.06 | 5.36 | 4.85 | 4.67 | 0.67 | |||||
Cash From Operations, 1 Yr. Growth % | 33.74 | -27.89 | 35.25 | -24.19 | -3.85 | |||||
Capital Expenditures, 1 Yr. Growth % | 16.68 | -5.5 | -4.61 | 5.13 | 14.32 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 10.67 | -24.12 | 70.06 | -36.33 | -10.78 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 10.3 | -23.57 | 69.23 | -35.38 | -10.58 | |||||
Dividend Per Share, 1 Yr. Growth % | 0 | 11.11 | 10 | 9.09 | 5 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 1.9 | 9.76 | -2.72 | -3.07 | 0 | |||||
Gross Profit, 2 Yr. CAGR % | 3.82 | 16.78 | 0.29 | 3.25 | 0.73 | |||||
EBITDA, 2 Yr. CAGR % | 9.25 | 8.78 | -6.08 | 0.04 | -4.62 | |||||
EBITA, 2 Yr. CAGR % | 8.73 | 8.4 | -6.52 | -3.2 | -5.74 | |||||
EBIT, 2 Yr. CAGR % | 13.8 | 29.39 | -4.63 | -3.52 | -9.24 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 20.14 | 83.76 | -7.23 | 7.54 | -7.46 | |||||
Net Income, 2 Yr. CAGR % | 20.64 | 78.45 | -7.71 | 8.03 | -10.77 | |||||
Normalized Net Income, 2 Yr. CAGR % | 10.62 | 20.36 | 0.81 | 10.37 | -13.61 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 20.57 | 78.67 | -7.78 | 8.11 | -11.05 | |||||
Accounts Receivable, 2 Yr. CAGR % | 9.24 | 6.98 | -8.98 | -7.19 | -3.15 | |||||
Inventory, 2 Yr. CAGR % | -3.5 | 6.18 | 11.99 | -2.41 | -17.16 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | -3.39 | -0.48 | 3.46 | -4.56 | -7.98 | |||||
Total Assets, 2 Yr. CAGR % | 5.49 | 4.08 | -0.86 | 3.26 | 1.21 | |||||
Tangible Book Value, 2 Yr. CAGR % | 22.15 | 33.57 | 23.1 | 2.13 | 0.72 | |||||
Common Equity, 2 Yr. CAGR % | 6.38 | 7.68 | 5.11 | 4.76 | 2.65 | |||||
Cash From Operations, 2 Yr. CAGR % | 28.42 | -1.8 | -1.25 | 1.25 | -14.63 | |||||
Capital Expenditures, 2 Yr. CAGR % | 16.51 | 5.01 | -5.06 | 0.14 | 9.63 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 35.71 | -8.36 | 11.36 | 2.54 | -26.37 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 34.97 | -8.19 | 11.53 | 3.07 | -25.68 | |||||
Dividend Per Share, 2 Yr. CAGR % | - | 5.41 | 10.55 | 9.54 | 7.03 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 1.98 | 2.37 | 3.33 | -0.98 | -2.88 | |||||
Gross Profit, 3 Yr. CAGR % | 4.06 | 6.69 | 6.78 | 6.3 | 0.08 | |||||
EBITDA, 3 Yr. CAGR % | 11.96 | 4.48 | 2.99 | -2.82 | -6.07 | |||||
EBITA, 3 Yr. CAGR % | 11.77 | 3.91 | 2.67 | -5.95 | -6.22 | |||||
EBIT, 3 Yr. CAGR % | 22.54 | 8.1 | 16 | -4.68 | -8.87 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 20.54 | 5.45 | 52.93 | -2.05 | -3.2 | |||||
Net Income, 3 Yr. CAGR % | 20.93 | 4.39 | 51.4 | -3.02 | -4.62 | |||||
Normalized Net Income, 3 Yr. CAGR % | 20.68 | 1.34 | 20.07 | -0.87 | -3.92 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 20.8 | 4.08 | 51.83 | -3.22 | -4.63 | |||||
Accounts Receivable, 3 Yr. CAGR % | 7.18 | 6.05 | -1.74 | -4.87 | -8.05 | |||||
Inventory, 3 Yr. CAGR % | -6.86 | 8.65 | 0.89 | 9.46 | -14.5 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | -1.13 | 0.18 | -0.53 | -0.64 | -5.59 | |||||
Total Assets, 3 Yr. CAGR % | 4.56 | 2.89 | 2.84 | 1.43 | 0.94 | |||||
Tangible Book Value, 3 Yr. CAGR % | 8.69 | 28.44 | 23.93 | 14 | 2.68 | |||||
Common Equity, 3 Yr. CAGR % | 3.94 | 6.04 | 6.73 | 4.96 | 3.38 | |||||
Cash From Operations, 3 Yr. CAGR % | 18.79 | 5.95 | 9.26 | -9.58 | -0.48 | |||||
Capital Expenditures, 3 Yr. CAGR % | 15.91 | 8.65 | 1.7 | -1.77 | 4.66 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 15.99 | 11.8 | 11.13 | -8.48 | -3.62 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 15.7 | 11.66 | 11.12 | -7.92 | -3.17 | |||||
Dividend Per Share, 3 Yr. CAGR % | 4 | - | 6.92 | 10.06 | 8.01 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 3.31 | 3.3 | 0.07 | 0.16 | 1.99 | |||||
Gross Profit, 5 Yr. CAGR % | 5.66 | 6.36 | 2.53 | 5.3 | 6.45 | |||||
EBITDA, 5 Yr. CAGR % | 12.17 | 6.83 | 4.36 | 1.84 | -1.2 | |||||
EBITA, 5 Yr. CAGR % | 12.44 | 6.78 | 4.06 | -0.33 | -1.94 | |||||
EBIT, 5 Yr. CAGR % | 20.96 | 14.03 | 10.85 | 2.32 | 3.85 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 38.47 | 5.91 | 8.55 | 6.28 | 25.09 | |||||
Net Income, 5 Yr. CAGR % | 40.13 | 5.26 | 8.54 | 5.83 | 22.54 | |||||
Normalized Net Income, 5 Yr. CAGR % | 17.13 | 6.36 | 12.3 | 3.57 | 3.85 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 39.98 | 5.01 | 8.44 | 5.67 | 22.59 | |||||
Accounts Receivable, 5 Yr. CAGR % | 7.63 | 4.85 | 0.4 | 0.54 | -2.31 | |||||
Inventory, 5 Yr. CAGR % | -4.8 | -1.48 | 0.26 | 4.08 | -6.76 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 9.98 | 11.22 | 0.68 | -1.75 | -3.58 | |||||
Total Assets, 5 Yr. CAGR % | 2.97 | 1.41 | 2.36 | 3.04 | 2.18 | |||||
Tangible Book Value, 5 Yr. CAGR % | -2.78 | 2.11 | 14.24 | 17.19 | 14.07 | |||||
Common Equity, 5 Yr. CAGR % | 3.43 | 3.25 | 4.4 | 5.53 | 5.08 | |||||
Cash From Operations, 5 Yr. CAGR % | 22.96 | 11.48 | 10.33 | 4.04 | -1.01 | |||||
Capital Expenditures, 5 Yr. CAGR % | 10 | 10.51 | 7.02 | 5.17 | 4.8 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 26.54 | 12.2 | 14.11 | 7.14 | -6.29 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 26.54 | 12.44 | 14.01 | 7.3 | -5.94 | |||||
Dividend Per Share, 5 Yr. CAGR % | 9.95 | 7.39 | 6.58 | - | 6.96 |
- Stock Market
- Equities
- TFI Stock
- Financials TF1
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















